Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists

Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists

US Patent 6967201 · Granted Nov 22, 2005

Estimated economic value: $247,860,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AT2R antagonists and uses thereof2024
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
(Trifluoromethyl)pyrimidine-2-amine compounds2023
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 2023
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 2023
(trifluoromethyl)pyrimidine-2-amine compounds2022
Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-ind2021
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2021
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 2021
Condensed thiophene derivatives useful as NaPi-IIb inhibitors2021
TG2 inhibitor piperazine compounds and uses thereof2021
6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds2020